Ribomic Inc. (4591) Reports Earnings: Operating Loss of 273 Million Yen

Ribomic Inc. (4591) has released its latest financial results, reporting net sales of 4 million yen, an operating loss of 273 million yen, an ordinary loss of 273 million yen, and a net loss of 270 million yen. Earnings per share (EPS) stood at -4.87 yen.

From a financial and valuation perspective, the equity ratio is 94.8%, interest-bearing debt is 0.0 billion yen, Return on Equity (ROE) is -38.93%, and Return on Assets (ROA) is -37.17%, reflecting ongoing profitability challenges characteristic of its development stage. Furthermore, EBITDA was -1.2 billion yen due to sustained investments in research and development, while retained earnings stood at -3.19 billion yen.